• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ramipril
    3 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Ramitens
    Rafa
    RX
    partial basket chart
    Ramitens

    ACE Inhibitor. Ramipril 10 mg.
    CAPS: 10 mg.
    Hypertens., CHF, reduct. mortality aft.
    M.I: Initial. (for pts. not on diuretics):
    2.5 mg 1 x dly. May incr. at intervals of
    2-3 wks. up to 5 mg 1 x dly to max: 10
    mg 1 x dly. Reduct. risk M.I, stroke or
    CV death and/or need for
    revascularizat: Initial: 2.5 mg 1 x dly.
    Depend. On tolerabil. grad. incr. to
    double after approx. 1 wk; aft. further
    3 wks. incr. to 10 mg. Maint: 10 mg 1 x
    dly. Pts already stabilized on lower
    doses for other indicats., where
    possible should be titrated to 10 mg 1
    x dly.
    Hypertens. congest. heart fail., reduct.
    mortality aft. M.I. with left ventric.
    dysfunct., reduce risk M.I., stroke, CV
    death, need for revascularizat. in pts. over
    55 yrs who have clinical evidence of CV
    dis. (prev. M.I., unstable angina,
    multivessel CABG or PTCA), stroke or
    periph. vasc. dis. Also for reducing risk of
    M.I., stroke, CV death or need for
    revascularizat. procedures in diabet. pts of
    55 yrs or more who have one or more of
    the foll. clin. findings: hypertens. (systol.
    pressure >160 mm Hg or diastol. pressure
    >90 mm Hg); high total cholesterol (>5.2
    mmol/L); low HDL (<0.9 mmol/L); current
    smoker; known microalbuminur.; clin.
    evidence of prev. vasc. dis., prevent.
    progress. ren. fail. in pts. suffer. from
    impair. ren. funct

    Tritace
    Sanofi
    RX
    partial basket chart
    Tritace

    ACE Inhibitor. Ramipril 1.25, 2.5, 5 mg.
    TABS: 28 x 1.25 mg, 2.5 mg, 5 mg.
    Hypertens., CCF, reduct. of mortality
    aft. M.I: Initial (for pt. not on diuretics):
    2.5 mg 1 x dly. May incr. at intervals of
    2-3 wks. up to 5 mg 1 x dly. to max. of
    10 mg 1 x dly. Reducing risk of M.I.,
    stroke or CV death and/or the need for
    revascularization procedures: Initial:
    2.5 mg 1 x dly. Depend. on tolerability,
    dose should be gradually increas. to
    double aft. about 1 wk. of tmt; then,
    aft. a further 3 wks, increase to 10 mg.
    Maint. dose: 10 mg 1 x dly. Pts already
    stabilised on lower doses for other
    indications where possible should be
    titrated to 10 mg 1 x dly.
    Hypertens. congest. heart fail., reduct.
    mortality aft. M.I., reduce risk M.I., stroke,
    CV death, need for revascularizat. in pts.
    over 55 yrs who have clinical evidence of
    CV dis. (prev. M.I., unstable angina,
    multivessel CABG or PTCA), stroke or
    periph. vasc. dis. Also for reducing risk of
    M.I., stroke, CV death or need for
    revascularizat. procedures in diabet. pts
    of 55 yrs or more who have one or more
    of the foll. clin. findings: hypertens.
    (systol. pressure >160 mm Hg or diastol.
    pressure >90 mm Hg); high total
    cholesterol (>5.2 mmol/L); low HDL (<0.9
    mmol/L); current smoker; known
    microalbuminur.; clin. evidence of prev.
    vasc. dis., prevent. progress. ren. fail. in
    pts. with persist. proteinur. in excess of 1
    g/day. Not suit. for tmt. hypertens. result.
    from prim. hyperaldosteronism.
    C/I: hypersens. histor. of angioed.
    2nd and 3rd trimester of reg., hypotens.
    Sig.bil. renal arter. stenos. See lit.

    Tritace Comp
    Sanofi
    RX
    partial basket chart
    Multiple ingredients
    Tritace Comp

    ACE Inhibitor, Thiazide. Hydrochlorothiazide 12.5 mg, 25 mg, Ramipril 2.5 mg, 5 mg.
    TABS: 28. Initial: 1 tab dly during or aft.
    meals. May incr. at intervals of 2-3 wks.
    if reqd. Max. dly dose: 10 mg
    ramipril/50 mg HTCZ. See lit.
    Essent. hypertens. when a comb. prep. is
    indicated.

    CLOSE